This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Metabolic Pharmaceuticals Limited. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Christopher Ian Belyea: Innovator in Obesity Control
Introduction
Christopher Ian Belyea is an accomplished inventor based in Elsternwick, Australia. He is known for his innovative contributions to the field of obesity control through his unique food and beverage products. His work focuses on utilizing transgenic plants to create solutions that can help manage lipid metabolism.
Latest Patents
Belyea holds a patent for a product and method aimed at controlling obesity. This invention relates to food and beverage products that incorporate a transgenic plant or its parts. The key feature of this invention is a nucleic acid molecule that encodes a C-terminal growth hormone fragment, which has the ability to modulate lipid metabolism. The transgenic plant can be used in the production of fermented food or beverage products, or it may be part of an edible plant, such as fruits or vegetables, including but not limited to tomato, banana, and potato. He has 1 patent to his name.
Career Highlights
Belyea is associated with Metabolic Pharmaceuticals Limited, where he applies his expertise in developing innovative solutions for obesity management. His work has the potential to make a significant impact on public health by addressing obesity through dietary products.
Collaborations
Some of his notable coworkers include Frank Man-Woon Ng and Paul Vaughan. Their collaboration contributes to the advancement of research and development in the field of metabolic health.
Conclusion
Christopher Ian Belyea is a notable inventor whose work in obesity control through innovative food and beverage products showcases the potential of transgenic plants. His contributions are paving the way for new approaches to managing obesity and improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile